- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02097030
Clinical Evaluation of Daily Disposable Contact Lenses
July 19, 2020 updated by: CooperVision, Inc.
Single-Center Clinical Evaluation of Daily Disposable Contact Lenses
The objective of the study is to compare the overall subjective preference of filcon II 3 daily disposable silicone hyrogel contact lenses compared to etafilcon A and nelfilcon A daily disposable conventional hydrogel contact lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Double-masked, randomised, controlled crossover trial.
Subjects were randomized to wear one or the other of the conventional hydriogel lenses; all subjects wore the filcon II 3 lenses.
The first randomly assigned lens type was worn for 3 days, with daily replacement, followed by 3 days of wear of the other lens type, with daily replacement.
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Berkeley, California, United States, 94720-2020
- University of California, Berkeley Clinical Research Center (UCB-CRC)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Is between 18 and 40 years of age (inclusive)
- Has had a self-reported visual exam in the last two years
- Is an adapted soft CL wearer
- Must be able to wear their lenses at least 3 full days, 10 hours per day, assuming there are no contraindications for doing so
- Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive)
- Has less than 1.25 D spectacle cylinder in each eye.
- Baseline vision of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected.
- Is correctable to at least 20/25 distance visual acuity with study contact lenses in each eye
- Has clear corneas and no active ocular disease
- Has read, understood and signed the information consent letter
- Is willing to comply with the wear schedule (at least 3 full days)
- Is willing to comply with the visit schedule
Exclusion Criteria:
- Has never worn contact lenses before.
- Currently wears rigid gas permeable contact lenses.
- Has a history of not achieving comfortable CL wear (3 days per week; > 8 hours/day)
- Has a CL prescription outside the range of - 1.00 to -6.00D
- Has a spectacle cylinder greater than -1.25D of cylinder in either eye.
- Has best corrected spectacle distance vision worse then 20/25 in either eye.
- Has any systemic disease affecting ocular health.
- Is using any systemic or topical medications, (includes rewetting drops, artificial tears and allergy drops), that will affect ocular health. Occasional use is acceptable but not during the trial.
- Has any ocular pathology or severe insufficiency of lacrimal secretion
- Has persistent, clinically significant corneal or conjunctival staining
- Has active neovascularization or any central corneal scars.
- Is aphakic.
- Is presbyopic.
- Has undergone corneal refractive surgery.
- Is participating in any other type of eye related clinical or research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: etafilcon A lens
Participants were randomized to either the etafilcon A or the nelfilcon A lens for three days and then both groups wore the filcon II 3 lens for three days, without washout period between lens types.
|
Participants wear a first pair of lenses for three days and then crossover and wear a second pair of lenses for three days.
Other Names:
|
|
Active Comparator: nelfilcon A lens
Participants were randomized to either the etafilcon A or the nelfilcon A lens for three days and then both groups wore the filcon II 3 lens for three days, without washout period between lens types.
|
Participants wear a first pair of lenses for three days and then crossover and wear a second pair of lenses for three days.
Other Names:
|
|
Active Comparator: filcon II 3 lens
Participants were randomized to either the etafilcon A or the nelfilcon A lens for three days and then both groups wore the filcon II 3 lens for three days, without washout period between lens types.
|
Participants wear a first pair of lenses for three days and then crossover and wear a second pair of lenses for three days.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Lens Preference - All Study Lenses
Time Frame: Study Exit
|
Participant's subjective response for overall lens preference after 3 days of daily disposable wear of each pair of lenses.
Surveyed at exit.
(4 possible ratings: Strongly prefer pair#1, Slightly prefer pair #1, Slightly prefer pair #2, Strongly prefer pair #2).
|
Study Exit
|
|
Overall Lens Preference - Hydrogel vs. Filcon II 3
Time Frame: Study Exit
|
Participant's subjective response for overall lens preference after 3 days of daily disposable wear of each pair.
Surveyed at exit.
(4 possible ratings: Strongly prefer pair#1, Slightly prefer pair #1, Slightly prefer pair #2, Strongly prefer pair #2).
|
Study Exit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Response for Comfort
Time Frame: Baseline and 3 day follow-up
|
Participant's subjective response for comfort measured at baseline and 3 day follow-up.
(Continuous Comfort Scale 0-100, 0=cannot be worn/causes pain, 100=cannot be felt ever)
|
Baseline and 3 day follow-up
|
|
Subjective Response for Vision
Time Frame: Baseline and 3 day follow-up
|
Participant's subjective response for vision measured at baseline and at 3 day follow-up of daily disposable wear of lenses.
(Vision Scale 0-100, 0=very blurry, 100=very clear).
|
Baseline and 3 day follow-up
|
|
Subjective Response for Insertion
Time Frame: Baseline
|
Participant's subjective response for insertion measured at baseline.
(Insertion Handling Scale 0-100, 0=very hard to handle, 100=very easy to handle).
|
Baseline
|
|
Subjective Response for Handling (Insertion and Removal)
Time Frame: 3 days follow-up
|
Participant's subjective response for handling (insertion and removal) measured at 3 day follow-up of daily disposable wear of lenses.
(Handling Scale 0-100, 0=very hard to handle, 100=very easy to handle).
|
3 days follow-up
|
|
Subjective Response for Dryness
Time Frame: 3 Days Follow-up
|
Participant's subjective response for dryness, measured at baseline and after 3 day follow-up of daily disposable wear of lenses.
(Dryness Scale 0-100, 0=Cannot be worn/extremely dry, 100=no dryness experienced at any time).
|
3 Days Follow-up
|
|
Overall Satisfaction, Vision
Time Frame: 3 Days Follow-up
|
Participant's subjective response for overall vision satisfaction.
Measured after 3 days daily disposable wear of lenses.
(4 point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied.
|
3 Days Follow-up
|
|
Overall Satisfaction, Comfort
Time Frame: 3 Days Follow-up
|
Participant's subjective response for overall comfort satisfaction.
Measured after 3 days daily disposable wear of lenses.
(4 point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied.
|
3 Days Follow-up
|
|
Overall Satisfaction, Handling
Time Frame: 3 Days
|
Participant's subjective response for overall handling satisfaction.
Measured after 3 days of daily disposable lens wear.
(4 point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied.
|
3 Days
|
|
Overall Satisfaction, Dryness
Time Frame: 3 Days Follow-up
|
Participant's subjective response for overall dryness satisfaction.
Measured after 3 days daily disposable wear of lenses.
(4 point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied.
|
3 Days Follow-up
|
|
Overall Satisfaction
Time Frame: 3 Days Follow-up
|
Participant's subjective response for overall satisfaction.
Measured after 3 days of daily disposable lens wear.
(4 point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied.
|
3 Days Follow-up
|
|
Lens Fit and Performance - Wettability (Baseline and 3 Days Follow-up)
Time Frame: Baseline and 3 days follow-up
|
The investigator's objective assessment for contact lens fit and performance - wettability.
Measured at baseline (10-15mins settling) for both study pairs.
Wettability (scale 0-4, 0.25 steps, 0=excellent, 4 severely reduced).
|
Baseline and 3 days follow-up
|
|
Lens Fit and Performance - Deposits (Baseline and 3 Days Follow-up)
Time Frame: Baseline and 3 days follow-up
|
The investigator's objective assessment for contact lens fit and performance - deposits.
Measured at baseline (10-15mins settling) for both study pairs.
Deposits (scale 0-4, 0.25 steps, 0=excellent, 4 severely reduced);
|
Baseline and 3 days follow-up
|
|
Lens Fit and Performance - Debris (Baseline and 3 Day Follow-up)
Time Frame: Baseline and 3 day follow-up
|
The investigator's objective assessment for contact lens fit and performance - debris.
Measured at baseline (10-15mins settling) for both study pairs.
(Debris scale 0-4; 0.25 steps; 0=no debris, 4=significant debris)
|
Baseline and 3 day follow-up
|
|
Lens Fit and Performance - Movement (Baseline and 3 Days Follow-up)
Time Frame: Baseline and 3 days follow-up
|
The investigator's objective assessment for contact lens fit and performance - movement.
Measured at baseline (10-15mins settling) for both study pairs.
Movement (scale in millimeters).
|
Baseline and 3 days follow-up
|
|
Lens Fit and Performance - Fit Acceptance
Time Frame: Baseline and 3 day follow-up
|
The investigator's objective assessment for contact lens fit and performance - fit acceptance.
Measured at baseline and 3 day follow-up (10-15mins settling) for both study pairs.
Fit acceptance (Scale 0-4, 0.25 steps, 0=Should not be worn, 4=Perfect).
|
Baseline and 3 day follow-up
|
|
Lens Fit and Performance - Tightness (Baseline and 3 Day Follow-up)
Time Frame: Baseline and 3 day follow-up
|
The investigator's objective assessment for contact lens fit and performance - tightness.
Measured at baseline (10-15mins settling) for both study pairs.
Tightness (Scale 0-4, 0.25 steps, 0=Should not be worn, 4=Perfect).
|
Baseline and 3 day follow-up
|
|
Ocular Health - Biomicroscopy
Time Frame: 3 Days Follow-up
|
The investigator's objective assessment of ocular health assessed for each study Pair after 3 days wear by biomicroscopy.
Bulbar and Limbal Hyperemia; Corneal Staining Type, Extent and Depth, Conjunctival Staining and Indentation.
BrienHolden Vision Institute Continuous Scale: 1-4, 0.5 steps (1=Very, 2=Slight, 3=Moderate, 4=Severe)
|
3 Days Follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Meng C Lin, OD, PhD, University of California, Berkeley
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
March 24, 2014
First Submitted That Met QC Criteria
March 24, 2014
First Posted (Estimate)
March 26, 2014
Study Record Updates
Last Update Posted (Actual)
July 31, 2020
Last Update Submitted That Met QC Criteria
July 19, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-46
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on etafilcon A
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited Kingdom
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.; Johnson & Johnson K.K. Medical CompanyCompleted
-
Johnson & Johnson Vision Care, Inc.Completed